Home > Financial Ratios > GLAND PHARMA
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -4.679.11-34.6021.3433.82

What is the latest EBIT Growth ratio of GLAND PHARMA ?

The latest EBIT Growth ratio of GLAND PHARMA is -4.67 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025-4.67
Mar20249.11
Mar2023-34.60
Mar202221.34
Mar202133.82

How is EBIT Growth of GLAND PHARMA Trending?

Years EBIT Growth % Change
Mar2025 -4.67
Negative
Mar2024 9.11
Positive
Mar2023 -34.6
Negative
Mar2022 21.34
-36.90
Mar2021 33.82 -

Other Financial Ratios of GLAND PHARMA


Compare EBIT Growth ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹30,769.8 Cr -2.8% 6.3% 32.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,075.0 Cr 0.4% 10.8% 10.5% Stock Analytics
DIVIS LABORATORIES ₹179,486.0 Cr 0.7% 9.5% 16.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,124.0 Cr -2.5% 6% 36.2% Stock Analytics
CIPLA ₹115,641.0 Cr 9.7% 16.7% -4.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,589.0 Cr 4.5% 9.7% 9% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-2.8%

6.3%

32.5%

SENSEX

-2.7%

-2.1%

-5.3%


You may also like the below Video Courses